Loading...
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx — Minocycline Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #13 buyer for Minocycline · $200.0K import value · 4 shipments · UNITED STATES · DGFT Verified
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx is the #13 importer of Minocycline from India with $200.0K in import value and 4 verified shipments. Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx holds a 0.9% market share in Minocycline imports based in UNITED STATES. Overall, Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports 3 pharmaceutical products worth $1.6M across 3 therapeutic categories.
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LTD | $5.7M | 113 | 1 |
| AUROBINDO PHARMA LIMITED | $1.4M | 27 | 1 |
| ALKEM LABORATORIES LIMITED | $632.8K | 37 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $465.1K | 10 | 2 |
| WATSON PHARMA PRIVATE LIMITED | $450.0K | 9 | 1 |
| TORRENT PHARMACEUTICALS LTD | $350.0K | 7 | 1 |
| TORRENT PHARMACEUTICALS LIMITED | $350.0K | 7 | 1 |
| ZYDUS LIFESCIENCES LIMITED | $300.0K | 6 | 2 |
| CADILA HEALTHCARE LTD | $200.0K | 4 | 1 |
| TITAN LABORATORIES PRIVATE LIMITED | $150.0K | 3 | 1 |
India's top Minocycline suppliers include AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, ALKEM LABORATORIES LIMITED. These companies represent the primary source of Minocycline exports from India, serving buyers like Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx in UNITED STATES and other global markets.
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 18 | ASCEND LABORATORIES,LLC | UNITED STATES | $218.2K | 11 | $19.8K |
| 12 | XXDUSXXORLXXIDEXXMCC | UNITED STATES | $200.0K | 4 | $50.0K |
| 13 | XXRREXX PHXXMA XXC XXMPOXXER XXIN XX6 4XX741XX ★ | UNITED STATES | $200.0K | 4 | $50.0K |
| 11 | AUROLOGISTICS LLC (AUROBINDO PHARM | UNITED STATES |
What Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx and other importers must comply with to import Minocycline from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $8.8M worth of Minocycline through 654 shipments from 92 suppliers to 34 countries, serving 131 buyers globally. Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports $200.0K of this total, accounting for 0.9% of India's Minocycline exports with 4 shipments from UNITED STATES.
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's average Minocycline order value is $50.0K per consignment, based on 4 shipments totaling $200.0K. Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx is based in UNITED STATES and ranks #13 among all Minocycline importers from India by value.
Top Indian Minocycline suppliers include AUROBINDO PHARMA LTD ($5.7M), AUROBINDO PHARMA LIMITED ($1.4M), ALKEM LABORATORIES LIMITED ($632.8K), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($465.1K), WATSON PHARMA PRIVATE LIMITED ($450.0K). These companies represent the primary source of Minocycline exports from India.
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx ranks #13 among 131 Minocycline importers from India with a 0.9% market share. The top 3 importers are AUROLOGISTICS LLC, (AUROBINDO PHARM ($2.5M), AUROLOGISTICS LLC (AUROBINDO PHARMA ($1.2M), AUROLOGISTICS LLC(AUROBINDO PHARMA ($1.2M). Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx processed 4 shipments from UNITED STATES.
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx imports 3 products worth $1.6M. Beyond Minocycline, top products include Citalopram, Isosorbide. View the complete Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Minocycline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx's Minocycline imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx
Full Company Profile →
3 products · $1.6M total trade · 3 categories
| $150.0K |
| 3 |
| $50.0K |
| 14 | AUROBINDO PHARMA USA INC | UNITED STATES | $150.0K | 3 | $50.0K |
Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx ranks #13 among 131 Minocycline importers from India. Average shipment value of $50.0K compared to the market average of $67.2K. The closest competitors by value are ASCEND LABORATORIES,LLC and XXDUSXXORLXXIDEXXMCC.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 34+ countries, 131+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Xxrrexx Phxxma XXC Xxmpoxxer Xxin XX6 4xx741xx.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Minocycline. For current order-level data, contact TransData Nexus.